0001415889-21-002817.txt : 20210604
0001415889-21-002817.hdr.sgml : 20210604
20210604161517
ACCESSION NUMBER: 0001415889-21-002817
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210602
FILED AS OF DATE: 20210604
DATE AS OF CHANGE: 20210604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDERSON DANIEL GRIFFITH
CENTRAL INDEX KEY: 0001834111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39746
FILM NUMBER: 21996624
MAIL ADDRESS:
STREET 1: C/O SIGILON THERAPEUTICS, INC.
STREET 2: 100 BINNEY STREET, SUITE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sigilon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001821323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474005543
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: STE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-336-7540
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: STE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4-06042021_040601.xml
X0306
4
2021-06-02
0001821323
Sigilon Therapeutics, Inc.
SGTX
0001834111
ANDERSON DANIEL GRIFFITH
C/O SIGILON THERAPEUTICS, INC.
100 BINNEY STREET STE 600
CAMBRIDGE
MA
02142
true
false
false
false
Common Stock
2021-06-02
4
S
0
200000
10
D
2022222
D
/s/ Matthew Kowalsky, Attorney-in-Fact
2021-06-04